Related Experiment Video
Updated: Mar 22, 2026
Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
Vancomycin-induced thrombocytopenia: a rare adverse effect in a patient -submitted to bone graft in the jaw
Carolina Ferrairo Danieletto1, Gustavo Zanna Ferreira2, Gustavo Jacobucci Farah3
1Master Student, Implantodonty, Araçatuba Dentistry School, UNESP - Universidade Estadual Paulista, Araçatuba, São Paulo, Brazil.
Introduction:
Thrombocytopenia is the reduction in the number of blood -platelets, which may be caused by -several different conditions such as sepsis, disseminated intravascular -clotting, and large blood losses. Additionally, in rare situations, thrombocytopenia may also be induced by the use of medicaments. One of these drugs is the vancomycin, a glycopeptide presently used against -serious infections involving Gram-positive bacteria such as the methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus.
Objective:
The objective of this study is to report on a case of serious vancomycin-induced thrombocytopenia in a patient infected with methicillin-resistant S. aureus after mandibular reconstruction with autogenous bone graft, and to draw attention to the importance of this clinically rare adverse effect.
Conclusion:
Vancomycin-induced thrombocytopenia is a rare condition, which is also a significant disorder that demands attention and the rapid identification and replacement of the antimicrobial agent.
Insights
Vancomycin can cause a rare but serious drop in platelet count (thrombocytopenia). Promptly identifying and switching this antibiotic is crucial for patient recovery.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Thrombocytopenia, a low platelet count, has diverse causes including sepsis and medication side effects.
- Vancomycin, a critical glycopeptide antibiotic, treats severe Gram-positive bacterial infections like MRSA.
Observation:
- This case report details severe vancomycin-induced thrombocytopenia in a patient with MRSA infection.
- The patient underwent mandibular reconstruction with an autogenous bone graft.
Findings:
- Vancomycin-induced thrombocytopenia is a rare but significant adverse drug reaction.
- Early detection and discontinuation of vancomycin are essential for managing this condition.
Implications:
- Highlights the importance of monitoring platelet counts in patients receiving vancomycin.
- Emphasizes the need for prompt recognition and management of drug-induced thrombocytopenia.
More Related Videos
09:09Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
13:16Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts
Published on: December 22, 2015
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:29Venous Thrombosis III: Interprofessional Care
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...